SGF29 and leukemia: Our histone mass spectrometry revealed a precise elimination of H3K9ac by targeting a single gene SGF29 (Fig. 4A), indicating the utility of SGF29 to serve as a selective and perhaps more effective target for H3K9ac blockade and leukemia therapy.